Cold Sore Medicine
Del Labs puts millions into Orajel promotion - Orajel Multi-Action Cold Sore Medicine - Brief Article UNIONDALE, N.Y. -- Del Labs is backing its new Orajel Multi-Action Cold Sore Medicine, along with its other Orajel brands, with a $9.5. million media campaign--$5.5 million of which will be dedicated specifically to supporting the company's cold and canker sore products. A national radio campaign kicked off in September and will run through March, capping off the cough and cold season, the company noted.
In addition, the company's Orajel Sensitive Toothpaste, introduced in the second quarter of this year, now has been accepted by the American Dental Association as a fluoride product that fights cavities and relieves teeth sensitivity.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2001 Gale Group
|
